| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 30, 2026 | Kalshi raises $1 billion at $40 billion valuation as prediction market giant expands into financial trading | Kalshi has raised $1 billion in fresh funding at a staggering $40 billion valuation, marking another milestone in the prediction market company’s rapid rise. But the bigger story isn’t the money. Kalshi is moving beyond betting on elections... |
| Oct 29, 2026 | Kalshi Raises $1 Billion Series G At $40 Billion Valuation For Prediction Market Platform | Kalshi has raised $1 billion in Series G funding at a $40 billion post-money valuation as the prediction market company expands into a broader range of financial products and international markets. The round was co-led by Wellington and Seq... |
| Oct 26, 2026 | Options Action
Cracking AI trade has Wall Street looking for a hedge. An ex-Citadel quant may have the answer | Jasper Zhang, ex-Citadel quant, runs Hyperbolic, a GPU exchange building software for “physical” GPU futures.
The platform allows investors to buy and sell GPU clusters, the units that power AI compute.
Zhang sees the technology as the firs... |
| Oct 23, 2026 | Zai Lab Raises $250 Million PIPE To Advance DLL3-Targeting ADC Zocilurtatug Pelitecan | Zai Lab has entered into an agreement to raise approximately $250 million through a private investment in public equity financing, with proceeds primarily earmarked for the global development of its DLL3-targeting antibody-drug conjugate zo... |
| Oct 22, 2026 | Soufflé Therapeutics Secures $135M Series B to Propel RNA Therapy Revolution | Boston-based Soufflé Therapeutics secured an oversubscribed $135 million Series B financing, spearheaded by Juvia Group. This substantial investment propels the RNA therapeutics innovator. Soufflé leverages its proprietary REMEDY platform, ... |
| Oct 19, 2026 | Souffle Therapeutics Nets $135M Series B |
BOSTON, MA, Souffle Therapeutics, a leading RNA therapies company aimed at advancing the next generation of therapies designed to help people live healthier lives, announced the close of an oversubscribed $135 million Series B financing le... |
| Oct 2, 2026 | Hedge funds deliver mixed September results on AI swings | HONG KONG/NEW YORK, Oct 7 : Global hedge funds delivered mixed results in September after surging bond yields, higher oil prices and swings in AI shares drove selling, while quant strategies posted gains, according to prime brokerage notes ... |
| Aug 10, 2026 | Expedition Therapeutics Closes $115 Million Series B |
SAN FRANCISCO, CA, Expedition Therapeutics, a clinical-stage biotechnology company developing novel oral small molecule therapies for inflammatory and respiratory diseases, announced the closing of an oversubscribed $115 million Series B f... |
| Aug 9, 2026 | Expedition Therapeutics Lands $115M Series B |
SAN FRANCISCO, CA, Expedition Therapeutics has announced the closing of an oversubscribed $115 million Series B financing round.
>> Click here for more funding data on Expedition Therapeutics
>> To export Expedition Therapeutic... |
| Aug 5, 2026 | Expedition Therapeutics Raises $115M in Series B Funding | Expedition Therapeutics, a San Francisco, CA-based clinical-stage biotechnology platform, raised $115M in Series B financing.
The round was led by General Atlantic with participation from RA Capital, Vivo Capital, Sofinnova Investments, Nov... |
| Jun 29, 2026 | Lycia Therapeutics Raises $75 Million Series D To Advance LYTAC Pipeline | Lycia Therapeutics announced that it has completed an oversubscribed $75 million Series D financing. The financing was co-led by existing investor Janus Henderson Investors and new investor Balyasny Asset Management. The round also included... |
| Jun 29, 2026 | Lycia Therapeutics Raises $75M in Series D Funding | Lycia Therapeutics, a South San Francisco, California-based developer of extracellular protein degradation and lysosomal targeting chimera (LYTAC) therapeutics, raised $75m in Series D funding.
The round was co-led by Janus Henderson Invest... |
| Jun 9, 2026 | Anthropic brings Mythos to the masses with Claude Fable 5, its most powerful generally available model ever | Anthropic today launched two new AI models — Claude Fable 5 and Claude Mythos 5 — marking the company’s first broad release of the powerful “Mythos-class” AI capabilities it previously made available only to participating organizations in i... |
| May 19, 2026 | Quince Therapeutics: $187 Million Private Placement And Orphai Acquisition To Advance Pulmonary Disease Pipeline | Quince Therapeutics announced the acquisition of Orphai Therapeutics along with a private placement financing valued at up to $187 million to expand its pulmonary disease pipeline. The acquisition adds Orphai’s lead program, LAM-001, an inh... |
| Nov 13, 2025 | Coding, autonomy and a new fund highlight a week of venture moves | Code Metal
This developer of technology for software developers to properly translate artificial intelligence code has fetched $36.5 million in Series A capital from investors to aid in its expansion push across industries with strict safet... |
| Nov 13, 2025 | Forterra: $238 Million Series C Raised To Expand Leadership In Defense Autonomy And Interoperable Mission Systems | Forterra, a leading developer of autonomous and interoperable systems for defense and logistics, has announced the closure of a $238 million Series C funding round, comprising both equity and debt. The round was led by Moore Strategic Ventu... |
| Nov 13, 2025 | Forterra Raises $238M in Series C Equity and Debt Funding | Forterra, a Clarksburg, MD-based company improving autonomy and mission system interoperability for defense and logistics, raised $238M in Series C funding.
The round was led by Moore Strategic Ventures, with participation from new investor... |
| Nov 13, 2025 | Forterra Raises $238 Million at a $1 Billion Valuation | Forterra is a high-growth autonomous defense technology company that is actively expanding the deployment of its self-driving systems for military and industrial customers. It focuses on equipping existing vehicles with its AutoDrive autono... |
| Oct 10, 2025 | Expedition Therapeutics Raises $165M in Funding | Expedition Therapeutics, a San Francisco, CA-based biotech company developing therapies for novel inflammatory and respiratory diseases, raised $165M in Series A financing.
The round was led by Sofinnova Investments and Novo Holdings, with ... |
| Oct 9, 2025 | Expedition resupplies for phase 2 COPD voyage with $165M series A | Expedition Therapeutics is gearing up for a phase 2 trek with a $165 million series A that closed Oct. 9. The new funding will fuel the Bay Area biotech’s DPP1 inhibitor EXPD-101 as it ventures into a study in patients with chronic obstruct... |
| Oct 9, 2025 | Expedition Therapeutics: $165 Million Series A Raised For Advancing DPP1 Inhibitor For COPD | Expedition Therapeutics, a biotechnology company dedicated to developing therapies for novel inflammatory and respiratory diseases, has closed an oversubscribed and upsized Series A financing round, raising $165 million. This financing roun... |
| Oct 4, 2025 | How hedge funds performed in September | How hedge funds performed in September
By Nell Mackenzie and Anirban SenOctober 3, 20259:24 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Traders work on the floor at the New York Stock Exchan... |
| Jan 11, 2023 | $17 billion hedge fund Balyasny has promoted 7 new partners, further sharing power in an industry known for larger-than-life founders with total authority | Dmitry Balyasny speaks at the 2018 Milken Conference in Beverly Hills, California. Lucy Nicholson/Reuters This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Balyasny Asset Management promote... |
| Feb 16, 2022 | Haul Keeps U.S. Supply Chain Flowing By Putting Truckers At The Wheel | Haul provides trucking companies a platform that allows them to connect with a pool of vetted, on-demand drivers to operate their trucks.
CUPERTINO, Calif. (PRWEB) February 16, 2022
Haul, the platform putting truckers at the wheel by connec... |
| Jul 19, 2021 | Here’s how Nature’s Fynd is approaching commercialization with its latest $350m funding | Nature’s Fynd, which grows protein by fermenting microbes that originate in the geothermal springs of the US’s Yellowstone National Park, has closed a $350 million Series C round led by SoftBank’s Vision Fund 2.
New investors including Blac... |
| Dec 21, 2017 | The Top 10 Farm Tech Deals of 2017 (How Many Can You Name Without Clicking?) | It was an exciting year in farm technology involving a few high profile venture capital exits and some of the largest deals on record.
In fact, funding records for this category and the subcategories within were broken more than once during... |
| May 2, 2017 | Orbital Insight closes $50M Series C led by Sequoia | This morning, Orbital Insight, a geospatial analytics startup, announced it had completed raising a $50 million Series C round of financing from Sequoia. The fresh capital brings the company’s total fundraising to $78.7 million.
Orbital Ins... |